Arcutis Biotherapeutics Inc
NASDAQ:ARQT

Watchlist Manager
Arcutis Biotherapeutics Inc Logo
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Watchlist
Price: 9.2 USD 0.88% Market Closed
Updated: May 19, 2024

Arcutis Biotherapeutics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcutis Biotherapeutics Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Operating Expenses
-$295.7m
CAGR 3-Years
-29%
CAGR 5-Years
-72%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$20.1B
CAGR 3-Years
-1%
CAGR 5-Years
-9%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$12.1B
CAGR 3-Years
9%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$12.5B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.7B
CAGR 3-Years
-21%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.3B
CAGR 3-Years
-22%
CAGR 5-Years
-15%
CAGR 10-Years
-19%

See Also

What is Arcutis Biotherapeutics Inc's Operating Expenses?
Operating Expenses
-295.7m USD

Based on the financial report for Dec 31, 2023, Arcutis Biotherapeutics Inc's Operating Expenses amounts to -295.7m USD.

What is Arcutis Biotherapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-72%

Over the last year, the Operating Expenses growth was 3%. The average annual Operating Expenses growth rates for Arcutis Biotherapeutics Inc have been -29% over the past three years , -72% over the past five years .